NCT06183671CompletedPhase 1
JX09 SAD/MAD in Healthy Participants
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multi-Part, Single and Multiple Ascending Dose Study of JX09 in Healthy Adult Participants
Source: ClinicalTrials.gov · Last updated 29 Oct 2026
Brief summary (registry, in English)
This is a phase 1, randomized, double-blind, placebo-controlled, multi-part, single and multiple ascending dose study in healthy adult to test the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect of JX09 when administered to healthy adult subjects.
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 92 (actual)
- First submitted
- 20 Nov 2023
- Start date
- 18 Jan 2024
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Ji Xing Pharmaceuticals Australia Pty Ltd
- Diseases
- High blood pressure
- NCT number
- NCT06183671
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 92
- From 18 Jan 2024 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Clinically significant oncologic, infectious, cardiovascular, pulmonary, hepatic, gastrointestinal, hematologic, metabolic, endocrine, neurologic, immunologic, renal, psychiatric, or other condition that in the opinion of the Investigator or Medical Monitor would make is unsafe for the participant to join the study or fulfill its requirements.
Lab values
- A clinical abnormality or abnormal laboratory parameter(s) in the opinion of the Investigator or Medical Monitor is likely to introduce additional risk or will affect data interpretation.
Other
- Postural tachycardia or hypotension.
- Female of childbearing potential who is pregnant, lactating, or planning to become pregnant.
Who the study is looking for
- Male or female aged 18 to 55 years (inclusive)
- In good health as deemed by the Investigator through a medical evaluation, including medical history, physical examination, and laboratory tests
- Body mass index (BMI) between 18 and 32 kg/m2, with a minimum weight of 50 kg at Screening
Age in the registry: 18 years to 55 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nucleus Network Pty Ltd Coordinator of this site? Confirm its status | Melbourne | Australia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.